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1. Introduction 
Since the first report in 1990, takotsubo cardiomyopathy (TTC) has been increasingly 
recognized as a novel form of nonischemic acute cardiomyopathy. It is an important 
differential in diagnosis of acute coronary syndrome (ACS) due to its similar presentation. 
However, it distinguishes itself from an ACS in the fact that regional wall motion 
abnormalities extend beyond a single coronary vascular bed and are reversible, and 
epicardial coronary occlusion is absent (1). 
In TTC, left ventricular (LV) dysfunction can be remarkably depressed but recovers within a 
few weeks (2) in the vast majority of patients. This syndrome has been described by more 
than 75 individual descriptive names in the literature, emphasizing those disease features 
that were most impressive to individual investigators (3) (Table 1).  
Increased awareness about this syndrome has led to its incorporation into the American 
Heart Association classification of reversible cardiomyopathies (4,5). Pathogenesis of this 
syndrome is still not well understood, although physical and emotional stressors and 
mediation by pathologic sympathetic myocardial stunning are believed to play key roles. 
However, in an important minority of patients, a detailed personal history does not elicit an 
antecedent event (3). 
 
Apical ballooning 
Apical ballooning syndrome 
Acute left ventricular apical ballooning syndrome 
Left ventricular apical ballooning syndrome 
Transient left ventricular apical ballooning syndrome 
Primary apical ballooning 
Transient apical ballooning 
Transient apical ballooning syndrome 
Transient cardiac apical ballooning syndrome 
Transient left apical ballooning syndrome 
Transient cardiac ballooning 
Left apical ballooning syndrome 
Acute apical ballooning syndrome 
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Cardiac apical ballooning syndrome 
Apical ballooning 
Apical ballooning without apical ballooning 
Apical ballooning cardiomyopathy 
Reversible apical ballooning of left ventricle 
Left ventricular ballooning syndrome 
Midventricular variant of transient apical ballooning 
Midventricular ballooning syndrome 
Transient left ventricular mid-portion ballooning 
Transient midventricular ballooning 
Transient midventricular ballooning cardiomyopathy 
Transient left ventricular nonapical ballooning 
Reverse or inverted left ventricular apical ballooning syndrome 
Inverted left ventricular apical ballooning syndrome 
Transient basal ballooning 
Tako-tsubo 
Takotsubo cardiomyopathy 
Takotsubo-like cardiomyopathy 
Takotsubo syndrome 
Takotsubo disease 
Takotsubo left ventricular dysfunction 
Takotsubo-like left ventricular dysfunction 
Takotsubo-like transient biventricular dysfunction 
Takotsubo-like transient left ventricular ballooning 
Takotsubo-shaped cardiomyopathy 
Takotsubo-shaped hypokinesia of left ventricle 
Takotsubo-type cardiomyopathy 
Takotsubo transient left ventricular apical ballooning 
Midventricular takotsubo cardiomyopathy 
Midventricular form of takotsubo cardiomyopathy 
Inverted takotsubo contractile pattern 
Inverted takotsubo cardiomyopathy 
Inverted takotsubo pattern 
Atypical takotsubo cardiomyopathy 
Reverse takotsubo syndrome 
Atypical basal type takotsubo cardiomyopathy 
Stress cardiomyopathy 
Acute stress cardiomyopathy 
Human stress cardiomyopathy 
Acute and reversible cardiomyopathy provoked by stress 
Stress-induced cardiomyopathy 
Stress-induced takotsubo cardiomyopathy 
Stress-induced apical ballooning syndrome 
Stress-related left ventricular dysfunction 
Stress-related cardiomyopathy 
Stress-related cardiomyopathy syndrome 
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Stress takotsubo cardiomyopathy 
Emotional stress-induced ampulla cardiomyopathy 
Midventricular stress cardiomyopathy 
Atypical transient stress-induced cardiomyopathy 
Stress-induced myocardial stunning 
Emotional stress-induced takotsubo cardiomyopathy 
Stress-associated catecholamine-induced cardiomyopathy 
Neurogenic stress syndrome 
Other 
Neurogenic stunned myocardium 
Adrenergic cardiomyopathy 
Broken heart syndrome 
Ampulla cardiomyopathy 
Ampulla-shaped cardiomyopathy 
“Chestnut-shaped” transient regional left ventricular hypokinesia 
Ball-shaped spherical dilation of left ventricular apex 
The artichoke heart 
Transient midventricular akinesia 
Transient antero-apical dyskinesia 
Reproduced from Sharkey et al. Why not just call it tako-tsubo cardiomyopathy: a discussion of 
nomenclature. J Am Coll Cardiol 2011;57:1496-1497, with permission from Elsevier. 
Table 1. Names Tabulated From Published Reports 
2. History 
In 1990, Sato and colleagues (6) first described a reversible cardiomyopathy as “tako-
tsubo-like left ventricular dysfunction.” One year later, Dote and colleagues (7) reported 5 
patients with a novel, acute cardiac condition characterized by distinctive regional left 
ventricular LV systolic dysfunction and transient LV apical ballooning in the absence of 
significant coronary artery disease. Other Japanese investigators were intrigued by the 
unusual end-systolic shape of the LV, which resembled the “tako-tsubo,” (a fisherman’s 
pot with a round bottom and narrow neck used for trapping octopuses) (2,8,9) (Figure 1). 
Consequently, the term takotsubo was introduced to describe a new cardiomyopathic 
syndrome characterized by reversible LV systolic dysfunction (3). Many reports were 
published from different countries afterwards, and it was first reported in the United 
States in 2004 (5). A search for the term “takotsubo cardiomyopathy” in MEDLINE 
returned 1,090 articles (Figure 2). 
3. Epidemiology 
A few case reports were published prior to 2000, but the recognition of takotsubo 
cardiomyopathy has increased gradually since 2001, and this condition probably accounts 
for 1% to 2% of all cases of suspected acute myocardial infarction (MI) (10,11). Given the 
relatively recent recognition of TTC, epidemiology of this condition is still emerging. TTC is 
reported to occur predominantly in postmenopausal women (82-100%) (12) soon after 
exposure to sudden, unexpected emotional or physical stress. Kushiro and colleagues 
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reported CD36 deficiency in a patient with stress-induced cardiomyopathy (13), suggesting 
an association between this entity and certain genetic profiles. This observation has led to 
the speculation that TTC might have a genetic component as described in a report by 
Cherian and colleagues (14). 
 
 
Fig. 1. Left ventriculograms obtained in a 65-year-old female who presented with acute 
shortness of breath. Panel A is a right anterior oblique (RAO) view of the left ventricle in the 
diastolic frame. Panel B is the RAO view of the left ventricle in the systolic frame. Note the 
dilated apical and akinetic outpouching of the left ventricle in Panel B. The coronaries in this 
patient were normal, consistent with the diagnosis of takotsubo cardiomyopathy. 
 
Fig. 2. Increase in the number of publications on MEDLINE® concerning takotsubo 
cardiomyopathy. (Originally published in Asia-Pacific Cardiology 2011;3:60-3. ©Touch 
Briefings. Reprinted with permission.) 
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4. Clinical presentation 
4.1 The patient 
TTC has characteristically been reported in women, with a median age varying from 61 to 76 
years in prior case series (2,9,11,15-21). All large-cohort reports of TTC have shown that 
most patients presenting with the syndrome are postmenopausal women (5). However, it 
has also been reported in men and patients <50 years (1,3,15,16) and even in a 2-year-old girl 
(22). In the first large Japanese series describing TTC, 76 patients were women, 12 were men, 
and the median age was 67 ± 13 years (2). 
4.2 The triggering event 
Different stresses prior to presentation have been reported to trigger TTC, but the common 
theme is a sudden physical or emotional stress. The numerous events precipitating TTC are 
depicted in Table 2. Recurrence of TTC has also been rarely reported with similar or 
different triggering events (recurrence range, 0 to 8%) (23). TTC has been reported to be 
associated with pheochromocytoma (24-27) and subarachnoid hemorrhage (28-31) in some 
published reports. 
 
Emotional stress 
Death or severe illness or injury of a family member, friend, or pet 
Receiving bad news—diagnosis of a major illness, daughter's divorce, spouse leaving 
for war 
Severe argument 
Public speaking 
Involvement with legal proceedings 
Financial loss—business, gambling 
Car accident 
Surprise party 
Move to a new residence 
Physical stress 
Non-cardiac surgery or procedure—cholecystectomy, hysterectomy 
Severe illness—asthma or chronic obstructive airway exacerbation, connective tissue 
disorders, acute cholecystitis, pseudomembranous colitis 
Severe pain—fracture, renal colic, pneumothorax, pulmonary embolism 
Recovering from general anesthesia 
Cocaine use 
Opiate withdrawal 
Stress test—dobutamine stress echo, exercise sestamibi 
Thyrotoxicosis 
Reproduced from Prasad et al. Apical ballooning syndrome (Tako-Tsubo or stress 
cardiomyopathy): A mimic of acute myocardial infarction. Am Heart J 2008;155:408-17, with 
permission from Elsevier. 
Table 2. Stressors Reported to Trigger Takotsubo Cardiomyopathy 
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4.3 The syndrome 
The characteristic clinical syndrome is acute LV dysfunction (10). Patients usually 
present with typical chest pain (70-90%) and dyspnea (20%) (10); other less common 
presentations include syncope (12), pulmonary edema and cardiac arrest. Dynamic 
electrocardiographic changes and elevated cardiac biomarkers (reflecting acute 
myocardial injury) are usually present. Coronary angiography, however, does not reveal 
any evidence of epicardial coronary obstruction. Left ventriculography (Figure 1) reveals 
LV dysfunction and wall motion abnormalities affecting apical and, frequently, 
midventricular myocardium but sparing the basal myocardium, changes which resemble 
a flask with a narrow neck and a round bottom shaped like the Japanese octopus trap 
“tako-tsubo” (32). Symptoms can be severe and lead to death in 2% of patients (3). Song 
and colleagues reported 32% (n=16) of their patients with TTC (n=50) presented with 
cardiogenic shock as initial presentation (33). Table 3 shows clinical features in a prior 
published series (10). 
4.4 Electrocardiography 
Most common electrocardiographic changes reported in TTC are ST-segment elevations in 
precordial leads (10) on admission (range, 46-100% of patients) (12). Subsequent deep 
symmetrical T-wave inversion in multiple leads and Q-wave formation (range, 6-31% of 
patients) (12) also are frequently found (10). Also present may be QT interval prolongation 
(5) (range, 450-501 ms) (12). The combination of clinical symptoms and electrocardiographic 
changes at patient’s initial presentation makes differentiation of TTC from ACS very 
difficult. A typical electrocardiogram obtained in one of our patients at presentation and 48 
hours later is shown in Figure 3. 
4.5 Cardiac biomarkers 
Most patients present with elevated cardiac biomarkers and have a modest peak in levels 
within 24 hours (15,19,34), but levels are markedly lower than would be anticipated on the 
basis of the extent of wall motion abnormalities and electrocardiogram findings (1). 
4.6 Left ventriculography 
Diagnosis of TTC is frequently made in the cardiac catheterization laboratory during left 
ventriculography as the patients are initially triaged as an ACS and are referred for urgent 
or emergency coronary angiography (35). Left ventriculography (Figure 4) reveals the classic 
appearance of left ventricle with dilated apex and akinetic apical or midventricular walls (or 
both) and a hypercontractile basal segment. However, more variants of TTC have been 
reported with diversity in patterns of regional LV systolic dyssynergy. Singh and colleagues 
(36) reported a series of 107 patients (age=66 ± 14 years, n=99 females) and observed the 
regional contractility phenotypes shown in Table 4. A study by Kurowski and colleagues 
(n=35 patients) identified 60% of patients to be typical (apical) and 40% to be atypical 
(midventricular) variants (11). Subclassifying TTC variants with different names should be 
avoided as it can lead to more confusion (3). The proposed alternate names – “transient 
ballooning syndrome” (37) or “transient stress-induced left ventricular dysfunction 
syndrome” – seem to capture the essential features of the disease, though takotsubo 
cardiomyopathy remains the most widely used. 
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LVEF indicates left ventricular ejection fraction; Retro, retrospective; Pro, prospective. Values are 
expressed as mean ± SD when appropriate. 
*Median. 
†In precordial leads. 
Adapted from Gianni et al. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic 
review. Eur Heart J 2006;27:1523–1529, with permission from Oxford University Press. 
Table 3. Patient Clinical and Laboratory Characteristics 
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Fig. 3. Electrocardiogram (ECG) changes in one of our patients with takotsubo 
cardiomyopathy. Panel A: ECG at presentation revealed a 1-mm elevation in V3 and V4 and 
a new-onset left bundle branch block. Panel B: ECG at 48 hours after presentation revealed 
T-wave abnormalities in multiple leads. 
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Posterobasal 1% 
Basal + midventricular 1% 
Diaphragmatic 2% 
Localized apical 2% 
Anterolateral 11% 
Complete midventricular 29% 
Classical takotsubo cardiomyopathy 54% 
Data compiled from Singh et al.36 
Table 4. Variants of Takotsubo Cardiomyopathy36 
4.7 Coronary angiography 
Coronary angiography on presentation fails to reveal any coronary obstruction or acute 
plaque rupture. However, patients with coronary artery disease can develop TTC. Kurisu 
and colleagues (38) reported 10% of patients in their series of takotsubo patients (total 
patients=97) had >75% coronary artery obstruction in a major coronary vessel, though 
coronary stenosis is uncommon in patients presenting with TTC (1), and absence of an acute 
coronary artery syndrome is a diagnostic criterion for diagnosis of TTC. 
4.8 Echocardiography 
Echocardiography also plays a pivotal role in the diagnosis of TTC. This is particularly 
so given the ability to rapidly perform bedside echocardiography with echo-Doppler 
imaging.  Accurate evaluation by echocardiography, particularly after coronary 
evaluation by catheterization, can assist in further defining the diagnosis, particularly, 
when echocardiography repeated after few days to weeks shows complete normalization 
of regional wall motion abnormalities and LV ejection fraction. Typically, TTC appears 
like an evolving acute anterior wall myocardial infarction (MI) with akinesia of the apex, 
apical anterior wall and septum (Figure 5). Left ventricular outflow tract obstruction, a 
transient phenomenon in TTC, can also be recognized by echocardiography. 
In contemporary clinical practice, three-dimensional speckle tracking echocardiography 
(3D-STE) can be used to assess myocardial mechanical function. It permits the calculation 
of complex myocardial mechanical parameters such as strain and strain rate, rotation, 
torsion, as well as LV volume and ejection fraction in three dimensions within minutes. It 
has been validated against sonomicrometry, magnetic resonance imaging (MRI) tagging, 
and found to be more accurate and reproducible than two-dimensional speckle tracking 
echocardiography (2D-STE). We have observed that the global longitudinal, 
circumferential and radial strains are all decreased significantly in acute anterior wall 
myocardial infarction and TTC in the acute phase. However, regional circumferential and 
radial strains at mid and apical LV are significantly lower in TTC patients than in acute 
anterior wall MI. 
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Fig. 4. Radiograph of the left ventricle. (A) Left ventriculogram in diastole. (B) Left 
ventriculogram in systole shows preserved contraction of the base of the ventricle and apical 
ballooning. (C) Right anterior oblique view in diastole. (D) Right anterior oblique view in 
systole. Note the hypercontractility of the basal and apical segments and ballooning of the 
midventricular segments. (E) After methamphetamine use in end-diastole. (F) After 
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methamphetamine use in end-systole. Basal segments are akinetic, the papillary level shows 
normal contractility, and the apex is hypercontractile. (G) Cardiac magnetic resonance 
image. Hypotension may be due to dynamic outflow tract obstruction caused by 
hyperkinesis of the basal left ventricle segments and systolic anterior motion of the mitral 
valve. Four-chamber, steady-state, free-precession image: end-diastole (left) and end-systole 
(center) show left and right ventricular apical akinesis. (Right) Three-chamber image in 
systole shows systolic anterior motion of the mitral leaflets (*) with dynamic left ventricular 
outflow tract obstruction; left ventricular apical mass consistent with thrombus (**). Ao = 
aorta; LA = left atrium; LV = left ventricle; RA = right atrium; RV = right ventricle. (Panels A 
and B are adapted from Hurst et al. Takotsubo cardiomyopathy: A unique cardiomyopathy 
with variable ventricular morphology. JACC: Cardiovascular Imaging 2010;3:641-9, with 
permission from Elsevier. Panels C and D are adapted from Hurst et al. Transient 
midventricular ballooning syndrome: a new variant. J Am Coll Cardiol 2006;48:579-83, with 
permission from Elsevier. Panels E and F are adapted from Reuss et al. Isolated left 
ventricular basal ballooning phenotype of transient cardiomyopathy in young women. Am J 
Cardiol 2007;99:1451-3, with permission from Elsevier. Panel G is adapted from Syed et al. 
Apical ballooning syndrome or aborted acute myocardial infarction? Insights from 
cardiovascular magnetic resonance imaging. Int J Cardiovasc Imaging 2008;24:875-82, with 
permission from Springer.) 
 
 
Fig. 5. Two-chamber view of the left ventricle, obtained in diastole (Panel A) and systole 
(Panel B), in a 56-year-old female who presented to the hospital in florid pulmonary edema 
after witnessing a car accident. Panel B demonstrates the akinetic and balloon apex in 
systole with a hypercontractile base, a classic variant of takotsubo cardiomyopathy. 
4.9 Cardiac magnetic resonance imaging 
Cardiac magnetic resonance imaging may be helpful in differentiating TTC from MI and 
myocarditis. TTC is characterized by the absence of delayed gadolinium enhancement, 
whereas MI is characterized by subendocardial delayed hyperenhancement and myocarditis 
is characterized by patchy delayed hyperenhancement (39-41). Cardiac magnetic resonance 
can also demonstrate the typical bulging of the LV apex and hypercontractile function of the 
base with accurate rendering of the LV stroke volume. It can also demonstrate the presence 
of LV thrombus in akinetic apex (Figure 6). 
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Fig. 6. Two-chamber Fast Imaging Employing Steady-State Acquisition (FIESTA) motion 
sensing in a 76-year-old female who presented to the hospital with chest pain and shortness 
of breath after witnessing an acute asthma attack in her grandchild. The figure demonstrates 
left ventricular apical bulging and a hypercontractile base with a 1.5 × 1.5-cm thrombus 
within the left ventricular apex. 
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4.10 Clinical outcome and prognosis 
A complete recovery of LV wall motion abnormalities is a hallmark of this syndrome in 
virtually all patients (2,15,16,35). Recovery time varies, from as short as several days to as 
long as 4-8 weeks, and is a requirement for the diagnosis (15). The diagnostic criteria are 
summarized in Table 5. 
 
1. Transient hypokinesis, akinesis, or dyskinesis of the left ventricular mid-segments with 
or without apical involvement; the regional wall motion abnormalities extend beyond a 
single epicardial vascular distribution; a stressful trigger is often, but not always, 
present.* 
2. Absence of obstructive coronary disease or angiographic evidence of acute plaque 
rupture. † 
3. New electrocardiographic abnormalities (either ST-segment elevation and/or T-wave 
inversion) or modest elevation in cardiac troponin. 
4. Absence of: 
Pheochromocytoma 
Myocarditis 
In both of the above circumstances, the diagnosis of takotsubo cardiomyopathy should be made with 
caution, and a clear stressful precipitating trigger must be sought. 
*There are rare exceptions to these criteria such as those patients in whom the regional wall motion 
abnormality is limited to a single coronary territory. 
†It is possible that a patient with obstructive coronary atherosclerosis may also develop takotsubo 
cardiomyopathy. However, this is very rare in our experience and in the published literature, perhaps 
because such cases are misdiagnosed as an acute coronary syndrome. 
Reproduced from Prasad et al. Apical ballooning syndrome (Tako-Tsubo or stress 
cardiomyopathy): A mimic of acute myocardial infarction. Am Heart J 2008;155:408-17, with 
permission from Elsevier. 
Table 5. Proposed Mayo Clinic Criteria for Takotusbo Cardiomyopathy 
The overall prognosis of TTC appears to be favorable in patients who survive the initial 
acute phase of heart failure. In-hospital mortality has been reported between 0 and 8% 
(12). Reported complications associated with TTC are left heart failure with and without 
pulmonary edema, cardiogenic shock, dynamic intraventricular obstruction with left 
ventricular intracavitary pressure gradient generation, mitral regurgitation resulting from 
chordal tethering as well as systolic anterior motion of the mitral valve apparatus, 
ventricular arrhythmias, LV mural thrombus formation, left ventricular free-wall rupture 
and death (12). Cardiogenic shock (6.5%), congestive heart failure (3.8%) and ventricular 
tachycardia (1.6%) are other known complications, while ventricular fibrillation, LV mural 
thrombus formation, ventricular septal defect, LV free wall rupture and pneumothorax 
have infrequently been reported (12,37). 
Recently, Madhavan and colleagues (42) have proposed the “Mayo Clinic Risk Score” 
system for acute heart failure in TTC (Table 6). The scoring system was developed  
to predict which patients with TTC are at risk of developing systolic heart failure. 
Presence of 1, 2 and 3 points was associated with 28%, 58% and 85% risk of acute heart 
failure. 
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Risk Factor Score 
Age > 70 years 1 
Presence of physical stressor 1 
Ejection fraction < 40% 1 
Table 6. Proposed Mayo Clinic Risk Scoring System of Acute Heart Failure in Takotsubo 
Cardiomyopathy 
5. Pathogenesis 
The aphorism “a broken heart” is well known to be associated with emotional stress by the 
lay person. Association of TTC with acute emotional and physical stress lends a scientific 
basis for this observation. But the exact underlying mechanism still proves elusive. Due to 
the recent recognition of TTC and its low incidence of diagnosis, as mentioned earlier, only a 
relatively small number of patients have been studied in a few published series. No large 
studies have confirmed the etiology of TTC (43). A rapidly accumulating body of evidence 
has led to very interesting insights into the possible pathophysiology of TTC. Most current 
hypotheses are based on cathecholamine surges in the setting of acute emotional or physical 
stress leading to catecholamine-related cardiac toxic effects (32,44-49) and was first 
suggested by Wittstein and colleagues (16). In this section we examine various 
advancements in understanding TTC pathophysiology. 
5.1 Obstruction of the left ventricular outflow tract 
Early investigators observed left ventricular outflow tract (LVOT) obstruction in some 
patients presenting with TTC. Villarreal and colleagues hypothesized that patients with a 
sigmoid interventricular septum, small LVOT, reduced LV volume (primarily elderly 
women) and an abnormal orientation of a slack mitral apparatus have a geometric 
predisposition to dynamic LVOT obstruction, which may manifest in the setting of intense 
adrenergic stimulation or hypovolemia (50,51). Elderly females seem to have a higher 
incidence of basal septal thickening (52), and this could become a substrate for LVOT 
obstruction leading to severe, transient midcavity obstruction in the setting of a 
cathecholamine surge (53). LVOT obstruction may cause or worsen hypotension due to LV 
systolic dysfunction by contributing to significant mitral regurgitation secondary to systolic 
anterior motion of mitral valve and dynamic LVOT obstruction (54). Presence of LVOT may 
change the management of TTC patients and is detailed in the treatment section of this 
chapter. However, incidence of LVOT obstruction in patients presenting with TTC in 
various studies has varied from 11-25% of patients (12,52,55) and is not observed in all 
patients. Its role in the pathogenesis of TTC is unclear, and it remains uncertain if LVOT 
obstruction is a cause or a consequence of TTC (49). 
5.2 Vasospasm of epicardial coronary arteries hypothesis 
Clinical presentation of TTC bears close resemblance to an acute MI. Therefore, early 
hypotheses speculated that an ischemic event triggered by transient coronary plaque 
rupture (56) or reversible coronary vessel spasm (7) was responsible for “stunning” the 
ventricle. A few authors reported finding a long left anterior descending artery (LAD) that 
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wrapped around the apex in their patients presenting with TTC, and it was hypothesized 
that transient obstruction of epicardial blood flow to the left ventricle in a given coronary 
bed may lead to the regional akinesis or “ballooning” typically observed in TTC. 
However, there are multiple problems with such an explanation. For one, the 
aforementioned coronary artery anatomy is not found on coronary angiography in all 
patients presenting with TTC. Secondly, spontaneous coronary vasospasm has been 
reported in only 2% of patients with TTC (12). Furthermore, an acute coronary vessel-
obstructing lesion has not been described in patients with TTC immediately after 
presentation (57) and has been proposed as an exclusion criterion (35) for TTC diagnosis. 
Thirdly, as mentioned earlier, there are reports of numerous phenotypes of TTC that 
present with regional hypokinesis that encompasses territories of the left ventricle not 
supplied by a single vessel (35). Fourthly, histological examination of cardiac tissue in 
patients with acute MI reveals polymorphonuclear inflammation, whereas TTC is 
associated with an interstitial mononuclear inflammatory response and considerable 
increase in extracellular matrix protein and contraction band necrosis—a unique form of 
myocyte injury characterized by hypercontracted sarcomeres and dense eosinophilic 
transverse bands associated with catecholamine-excess states like pheochromocytoma and 
subarachnoid hemorrhage (16,49). Finally, provocative tests with infusion of ergometrine 
or acetylcholine for inducible coronary vasospasm in patients with TTC were only 
positive in 28.6% of patients (55) and 27.6% of patients (58) in two published series, 
respectively. These equivocal results combined with the factors mentioned above make 
obstruction of blood flow in epicardial coronary vessels seem less likely to explain the 
pathophysiology of TTC. 
5.3 Coronary microvascular blood flow abnormalities 
Several investigators (11,19,59) have suggested microvascular dysfunction to be a 
potential pathophysiologic mechanism in TTC. Kume and colleagues demonstrated 
microcirculation disturbances in patients with TTC by use of Doppler flow-wire 
assessment (60). Other investigators have used TIMI (Thrombolysis in Myocardial 
Infarction) frame counts to assess coronary blood flow. Using this technique, Kurisu (59) 
and colleagues found significantly higher frame counts in TTC compared to a control 
group. Bybee and colleagues (19) also found abnormal TIMI frame counts in one or more 
major epicardial vessels in patients with TTC in their published series. These findings 
suggest that microvascular integrity in TTC is impaired in all coronary arteries in many 
patients, and the microvascular dysfunction in LAD is comparable to that of patients with 
acute anterior ST-segment elevation myocardial infarction after recanalization of the 
infarct-related artery. 
Nuclear studies with single-photon emission tomography (SPET) and fluorodeoxyglucose 
positron emission tomography (FDG-PET) were performed by Kurowski (11) in their 
patients with TTC and revealed that myocardial glucose metabolism was more affected than 
perfusion. The authors concluded that this “inverse mismatch” pattern is similar to that seen 
in postischemic “stunned” myocardium (61). 
These findings indicate that diffuse coronary microvascular dysfunction is present in 
patients with TTC. However, whether this is an effect or cause of this syndrome is unclear 
(10). This type of microvascular dysfunction, however, can be a result of a surge in 
catecholamine secretion, which is described in detail later in this chapter. 
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5.4 Catecholamine-induced acute myocardial stunning hypothesis 
5.4.1 Alterations in calcium handling 
Akashi and colleagues were the first to report elevated serum catecholamine levels in 
patients with TTC (62). Wittstein and colleagues (16) later reported supraphysiologic 
levels of plasma catecholamines in their series (n=19 patients), which reported plasma 
levels of epinephrine, norepinephrine and dopamine in patients with TTC to be 2-3 times 
higher than those of patients with Killip class III MI and 7-32 times higher than the 
published normal values (63). They also noted higher levels of both neuronal 
(dihydroxyphenylglycol, dihydroxyphenylglycol and dihydroxyphenylacetic acid) and 
extraneuronal catecholamines (metanephrine, normetanephrine and neuropeptide Y). In 
Wittstein’s series, the plasma cathecholamine levels trended downward by day 7-9 but 
still remained elevated. They concluded that TTC was associated with activation of 
adrenomedullary hormonal system and enhanced sympathoneural activity. Similarly, 
administration of epinephrine at suprapharmacological doses led to induction of stress 
cardiomyopathy in two cases (64,65). Several investigators (16,32,66) have suggested 
direct myocardial stunning as a result of the catecholamine surges. Such a stunning 
could possibly explain the findings in TTC. Catecholamine-overload state is associated 
with the following histologic changes: 1.) increased production of extracellular matrix 
leading to a rapid increase in fibrosis; 2.) contraction band necrosis; and 3.) mild 
neutrophil infiltration (44). There is increased production of oxygen-derived free radicals 
(67) that interfere with sodium and calcium transporters, resulting in myocyte 
dysfunction through increased transsarcolemmal calcium influx and cellular calcium 
overload (68). Mori and colleagues (69) demonstrated that apical myocardium has a 
higher concentration of beta-adrenoceptors with a concentration gradient decreasing 
from apex to base. This could explain the enhanced responsiveness to sympathetic 
stimulation potentially making the apex more vulnerable to sudden surges in circulating 
catecholamine levels and, thus, could explain the typical phenotype most commonly 
found in TTC patients (16). 
Investigators have noted disturbance of the calcium regulatory system in stress-induced 
cardiomyopathy. Some animal models have been shown to describe altered expression of 
the calcium regulatory system protein genes by supraphysiological levels of catecholamines 
(70,71) (Figure 7). 
Sarcolipin regulates sarcoplasmic/endoplasmic reticulum calcium ATPase2 (SERCA) by 
lowering its affinity for calcium. Elevated catecholamines in TTC cause increased 
expression of sarcolipin in the acute phase, leading to reduced affinity of SERCA2 for 
calcium (49,72,73). Elevated levels of catecholamines also lead to reduced expression of 
SERCA2 messenger RNA levels through intense G-protein-stimulated ┚1 and ┚2 
adrenergic receptor signaling in animal models (74). The G-protein-stimulated ┚1-
adrenergic receptor and ┙1-adrenergic receptor can directly modulate SERCA2 gene 
expression (via cyclic AMP-responsive element binding protein 1 and calcineurin-nuclear 
factor of activated T cells signaling pathways) (75). Excessive adrenergic signaling could 
thus explain the cardiotoxicity observed in patients with stress cardiomyopathy from 
cardiomyocytes calcium overload, mitochondrial calcium overload, reactive oxygen 
species production and oxidative stress (32,49). However, there is no evidence to suggest 
that alterations in expression of calcium-handling proteins are responsible for the acute 
deleterious effects of TTC (49). 
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Fig. 7. The pathomechanistic concept of stress cardiomyopathy. Overexpression of 
catecholamines following a stress event leads to a number of changes that can have either 
protective or adverse effects. Abbreviations: ┚-ADR, ┚-adrenergic receptor; ANGII, 
angiotensin II; CASP, caspase; mTOR, mammalian target of rapamycin; PI3K–AKT, 
phosphatidylinositol 3 kinase–AKT; ROS, reactive oxygen species; TGF-┚, transforming 
growth factor ┚. Reproduced from Nef et al. Mechanisms of stress (Takotsubo) 
cardiomyopathy. Nat Rev Cardiol 2010;7:187–193, with permission from Nature Publishing 
Group. 
5.4.2 Stimulus trafficking 
5.4.2.1 Stimulus trafficking causes negative inotropism 
Human ventricular cardiomyocytes have two types of ┚-adrenergic receptors (AR), ┚1 and 
┚2, but the concentration of ┚2 is higher than ┚1 (4:1) (76). At physiological and elevated 
concentrations, norepinephrine and epinephrine act via ┚1-AR exerting positive inotropic 
and lusitropic responses through coupling with the Gs protein family. Epinephrine has 
higher affinity for ┚2-AR and activates the Gs protein family, causing positive inotropic 
response. However, at supraphysiological levels, epinephrine stimulates a negative 
inotropic effect (77) by causing a switch from ┚2-AR Gs protein signaling to ┚2-AR Gi 
protein signaling (78), a process called stimulus trafficking (32). Intense activation of the ┚1-
AR Gs protein and ┚2-AR Gs protein pathways is thought to initiate the switch in signal 
trafficking from ┚2-AR Gs protein to ┚2-AR Gi protein coupling (79). The Gi protein 
pathway exerts a negative inotropic effect through multiple pathways (32). 
After the surge in epinephrine levels has cleared from the circulation, negative inotropy-
causing ┚2-ARs that are coupled to Gi proteins either switch back to Gs protein coupling or 
are internalized and degraded, enabling cardiomyocytes to recover their inotropic function. 
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This sequence of events would explain the reported recovery of ventricular function in 
individuals with stress cardiomyopathy (32). 
5.4.2.2 Typical TTC phenotype explained by stimulus trafficking 
In human hearts, the density of the sympathetic nerve endings is approximately 40% 
greater at the base compared to the apex (80), whereas the concentration of ┚-ARs is 
higher in the apical myocardium (69). It has been proposed that the concentration of ┚-
ARs in the apical myocardium is increased to compensate for the decrease in the direct 
sympathetic innervation, thereby maintaining a balanced responsiveness of the ventricle-
to-sympathetic drive (32). Thus, the apex might be more sensitive and responsive to 
circulating catecholamines. An increasing density of ┚2-ARs from the base to the apex 
could explain the regional difference in response to high catecholamine levels, with 
circulating epinephrine having a greater influence on apical function, relative to basal 
function. 
5.5 Atypical phenotype 
Certain factors can influence the local epinephrine concentration in the myocardium. A 
study in rabbits demonstrated conversion of norepinephrine to epinephrine by 
phenylethanolamine N-methyltransferase in the ventricular myocardium (81). Thus, 
regional differences in epinephrine concentrations can play a role in responsiveness of the 
myocardium to catecholamines and could explain atypical phenotypes observed in some 
TTC patients (32). 
5.6 Female predominance related to hormones 
Some investigators have suggested reduction of estrogen levels in postmenopausal females 
to be one of the underlying factors of TTC. 
Estrogen receptors are expressed on cardiomyocytes (82), thus cardiomyocyte function 
could be directly affected by estrogen levels. Estrogen has also been shown to significantly 
suppress SERCA2 expression in ovariectomized rats compared to controls, thus altering 
cardiac myocyte sarcoplasmic reticulum calcium uptake (83). In the latter study, 
investigators noted that estrogen and progesterone supplementations were equally effective 
in preventing changes in ovariectomized hearts. 
Men rarely develop stress cardiomyopathy yet are physiologically estrogen-deficient, which 
suggests that this syndrome is not due to ovarian hormone deficiency. However, effects of 
hormone deficiency on contractility in the presence of excessive catecholamine levels need 
further clarification (49). 
5.7 Possible familial link 
Burgdorf and colleagues (84) recently reported a series of 144 patients with TTC (107 typical 
cases and 34 atypical cases) in which 26 patients were known to have cancer, while 7 
patients were newly diagnosed with cancer. On basis of this observation, they proposed that 
an association between cancer and TTC cannot be excluded and that patients diagnosed 
with TTC should undergo screening for cancer. While there might be an association, one 
possible confounder could be the neurally mediated hypothesis of stress associated with 
learning about the diagnosis of cancer. 
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6. Treatment 
TTC is a self-limiting syndrome; cardiac function returns to pre-TTC levels within a few 
weeks and patients carry a favorable prognosis (2). However, patients require standard 
supportive treatment during the acute phase. This treatment is similar to a congestive 
heart failure treatment regimen with diuretics and vasodilators (16). Vasopressors and 
beta-agonists should be avoided due to catecholamine-surplus state. Also, epinephrine 
administered may drive further ┚2-AR, Gi protein-mediated negative inotropism (32). Use 
of ┚-blockers should be carefully considered as some ┚-blockers can also cause stimulus 
trafficking of ┚2-ARs to Gi protein coupling (85), which, in the acute phase of TTC, can 
lead to further suppression of LV function. However, in the long term, ┚2-AR/Gi 
coupling may enhance the ability of ┚-blockers to protect and improve the function of the 
failing heart (85). Mechanical circulatory support in patients with intraaortic balloon 
counter pulsation (IABP) is appropriate to avoid vasopressor support in these patients 
(16). Administration of intravenous calcium or levosimendan (a calcium-sensitizing agent) 
has also been suggested as the inotrope of choice in TTC patients (86,87), but has not been 
clinically validated in any major study. Some investigators have used it to avoid IABP in 
TTC patients (88). In patients with moderate to severe hemodynamic compromise and 
echocardiographic evidence of significant LVOT obstruction (with a dynamic gradient 
possibly accompanied by systolic anterior motion of mitral valve), both IABP counter 
pulsation and inotropes are relatively contraindicated because they could worsen the 
dynamic gradient and thereby further jeopardize cardiac function (54,89); treatment 
should instead be more conservative with careful fluid management  to avoid excessive 
preload reduction, ┚-blockers if tolerated (to increase diastolic filling time and thus end-
diastolic volume) and occasionally peripheral vasoconstrictors (54,90,91). Finally, in 
patients with life-threatening acute left ventricular failure, temporary use of a LV assist 
device may be required (32). 
7. Conclusion 
Takotsubo cardiomyopathy is a unique form of transient nonischemic stress-induced 
cardiomyopathy. A well-recognized syndrome now, two decades after its first reported case, 
it is also being reported in populations other than postmenopausal women. Even though 
apical ballooning phenotype is the most common and typical presentation, much confusion 
has resulted from various nomenclatures being used for different presentations of this 
syndrome. The underlying mechanism is not fully understood but could be common and 
explained by changes in molecular pathways like stimulus trafficking under 
supraphysiological levels of catecholamines, and influenced by hormonal status. Clinical 
history, electrocardiogram and diagnostic imaging with coronary angiography and/or 
cardiac magnetic resonance imaging that establishes typical phenotypic features of the 
disease in absence of significant obstructive coronary artery disease are essential for 
diagnosis and to differentiate it from an acute myocardial infarction. Management focuses 
on supportive care in the acute phase, while avoiding vasopressor medications. Mortality is 
low if patients survive the initial critical period and, by definition, they go on to have a full 
recovery. Recurrence has been reported but is rare. More studies are needed to fully 
understand the underlying mechanisms. 
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